These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8865631)

  • 41. Human efferent adaptation of DPOAEs in the L1,L2 space.
    Meinke DK; Stagner BB; Martin GK; Lonsbury-Martin BL
    Hear Res; 2005 Oct; 208(1-2):89-100. PubMed ID: 16019174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distortion product otoacoustic emission generation mechanisms and their dependence on stimulus level and primary frequency ratio.
    Botti T; Sisto R; Sanjust F; Moleti A; D'Amato L
    J Acoust Soc Am; 2016 Feb; 139(2):658-73. PubMed ID: 26936550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age-related shifts in distortion product otoacoustic emissions peak-ratios and amplitude modulation spectra.
    Lai J; Bartlett EL
    Hear Res; 2015 Sep; 327():186-98. PubMed ID: 26232530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequency responses of two- and three-tone distortion product otoacoustic emissions in Mongolian gerbils.
    Mills DM
    J Acoust Soc Am; 2000 May; 107(5 Pt 1):2586-602. PubMed ID: 10830382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wave and place fixed DPOAE maps of the human ear.
    Knight RD; Kemp DT
    J Acoust Soc Am; 2001 Apr; 109(4):1513-25. PubMed ID: 11325123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Relationship between distortion product otoacoustic emissions and frequency discrimination in normal-hearing and hearing-impaired ears].
    Tanaka Y
    Nihon Jibiinkoka Gakkai Kaiho; 1996 Jan; 99(1):65-78. PubMed ID: 8822256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modifications of a single saturating non-linearity account for post-onset changes in 2f1-f2 distortion product otoacoustic emission.
    Lukashkin AN; Russell IJ
    J Acoust Soc Am; 2002 Oct; 112(4):1561-8. PubMed ID: 12398462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Observations of Distortion Product Otoacoustic Emission Components in Adults With Hearing Loss.
    Prieve BA; Thomas L; Long G; Talmadge C
    Ear Hear; 2020; 41(3):652-662. PubMed ID: 31569117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distortion product otoacoustic emissions created through the interaction of spontaneous otoacoustic emissions and externally generated tones.
    Norrix LW; Glattke TJ
    J Acoust Soc Am; 1996 Aug; 100(2 Pt 1):945-55. PubMed ID: 8759948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of short-term tone exposure on DPOAEs].
    Shi Y; Jiang S; Gu R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Feb; 32(1):41-4. PubMed ID: 10743127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Slow variation of the amplitude of acoustic distortion at f2-f1 in awake rabbits.
    Whitehead ML; Lonsbury-Martin BL; Martin GK
    Hear Res; 1991 Feb; 51(2):293-300. PubMed ID: 2032963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating cochlear filter response properties from distortion product otoacoustic emission (DPOAE) phase delay measurements in normal hearing human adults.
    Bowman DM; Eggermont JJ; Brown DK; Kimberley BP
    Hear Res; 1998 May; 119(1-2):14-26. PubMed ID: 9641315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In search of basal distortion product generators.
    Withnell RH; Lodde J
    J Acoust Soc Am; 2006 Oct; 120(4):2116-23. PubMed ID: 17069309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical significance of probe-tone frequency ratio on distortion product otoacoustic emissions.
    Nielsen LH; Popelka GR; Rasmussen AN; Osterhammel PA
    Scand Audiol; 1993; 22(3):159-64. PubMed ID: 8210955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The clinical use of oto-acoustic emissions of cochlear distortion products].
    Hauser R; Probst R; Harris FP
    Laryngorhinootologie; 1991 Mar; 70(3):123-31. PubMed ID: 2036146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distortion product otoacoustic emissions and basilar membrane vibration in the 6-9 kHz region of sensitive chinchilla cochleae.
    Rhode WS
    J Acoust Soc Am; 2007 Nov; 122(5):2725-37. PubMed ID: 18189565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distortion product otoacoustic emissions in normal and hearing-impaired ears.
    Probst R; Hauser R
    Am J Otolaryngol; 1990; 11(4):236-43. PubMed ID: 2240411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distortion product otoacoustic emissions in human newborns and adults. I. Frequency effects.
    Lasky RE
    J Acoust Soc Am; 1998 Feb; 103(2):981-91. PubMed ID: 9479751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Latency and multiple sources of distortion product otoacoustic emissions.
    Stover LJ; Neely ST; Gorga MP
    J Acoust Soc Am; 1996 Feb; 99(2):1016-24. PubMed ID: 8609284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.